Simulect and Haemolytic anaemia - a phase IV clinical study of FDA data

Summary:

Haemolytic anaemia is reported as a side effect among people who take Simulect (basiliximab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cellcept, and have High blood pressure.

The phase IV clinical study analyzes which people have Haemolytic anaemia when taking Simulect. It is created by eHealthMe based on reports of 3,859 people who have side effects when taking Simulect from the FDA, and is updated regularly.

What is Simulect?

Simulect has active ingredients of basiliximab. eHealthMe is studying from 3,861 Simulect users. Check the latest studies of Simulect.

What is Haemolytic anaemia?

Haemolytic anaemia (anaemia due to haemolysis) is found to be associated with 780 drugs and 1,040 conditions by eHealthMe. Check the latest studies of Haemolytic anaemia.

On Jul, 05, 2026

3,859 people reported to have side effects when taking Simulect.
Among them, 25 people (0.65%) have Haemolytic anaemia.

Could Simulect cause Haemolytic anaemia?

Among these 25 people:

How long have people been on Simulect when they have Haemolytic anaemia? *

What is the gender of people who have Haemolytic anaemia when taking Simulect? *

female: 84 %
male: 16 %

What is the age of people who have Haemolytic anaemia when taking Simulect? *

What are other drugs people take besides Simulect? *

Cellcept: 19 people, 76.00%
Prograf: 9 people, 36.00%
Neoral: 7 people, 28.00%
Tacrolimus: 7 people, 28.00%
Prednisolone: 5 people, 20.00%
Sandimmune: 5 people, 20.00%
Omeprazole: 4 people, 16.00%
Methylprednisolone Acetate: 3 people, 12.00%
Rituxan: 3 people, 12.00%
Zovirax: 3 people, 12.00%

What are other side effects people have besides Haemolytic anaemia? *

Thrombocytopenia (decrease of platelets in blood): 10 people, 40.00%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 5 people, 20.00%
Haemoglobin Decreased: 5 people, 20.00%
Anti-Erythrocyte Antibody Positive: 5 people, 20.00%
Cytomegalovirus Infection: 4 people, 16.00%
Renal Impairment (severely reduced kidney function): 4 people, 16.00%
Haptoglobin Decreased: 4 people, 16.00%
Blood Lactate Dehydrogenase Increased: 4 people, 16.00%
Red Blood Cell Abnormality (abnormal red blood cells): 4 people, 16.00%
Kidney Transplant Rejection: 4 people, 16.00%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 12.00%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 2 people, 8.00%
Kidney Transplant Rejection: 2 people, 8.00%
Immunodeficiency Disorders: 2 people, 8.00%
Urination - Excessive Volume: 1 person, 4.00%
Stress And Anxiety: 1 person, 4.00%
Hypersensitivity: 1 person, 4.00%
Gastric Ulcer (stomach ulcer): 1 person, 4.00%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Simulect and have Haemolytic anaemia?

- Check whether Haemolytic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simulect:

Simulect (3,861 reports)

Browse all side effects of Simulect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemolytic anaemia:

Haemolytic anaemia (780 drugs)

Browse all the conditions that are associated with Haemolytic anaemia:

Haemolytic anaemia (1,040 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on basiliximab (the active ingredients of Simulect) and Simulect (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.